Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Circulation ; 135(24): 2389-2402, 2017 Jun 13.
Article in English | MEDLINE | ID: mdl-28377485

ABSTRACT

BACKGROUND: Cerebral tissue damage after an ischemic event can be exacerbated by inflammation and thrombosis. Elevated extracellular ATP and ADP levels are associated with cellular injury, inflammation, and thrombosis. Ectonucleoside triphosphate diphosphohydrolase-1 (CD39), an enzyme expressed on the plasmalemma of leukocytes and endothelial cells, suppresses platelet activation and leukocyte infiltration by phosphohydrolyzing ATP/ADP. To investigate the effects of increased CD39 in an in vivo cerebral ischemia model, we developed a transgenic mouse expressing human CD39 (hCD39). METHODS: A floxed-stop sequence was inserted between the promoter and the hCD39 transcriptional start site, generating a mouse in which the expression of hCD39 can be controlled tissue-specifically using Cre recombinase mice. We generated mice that express hCD39 globally or in myeloid-lineage cells only. Cerebral ischemia was induced by middle cerebral artery occlusion. Infarct volumes were quantified by MRI after 48 hours. RESULTS: Both global and transgenic hCD39- and myeloid lineage CD39-overexpressing mice (transgenic, n=9; myeloid lineage, n=6) demonstrated significantly smaller cerebral infarct volumes compared with wild-type mice. Leukocytes from ischemic and contralateral hemispheres were analyzed by flow cytometry. Although contralateral hemispheres had equal numbers of macrophages and neutrophils, ischemic hemispheres from transgenic mice had less infiltration (n=4). Transgenic mice showed less neurological deficit compared with wild-type mice (n=6). CONCLUSIONS: This is the first report of transgenic overexpression of CD39 in mice imparting a protective phenotype after stroke, with reduced leukocyte infiltration, smaller infarct volumes, and decreased neurological deficit. CD39 overexpression, either globally or in myeloid lineage cells, quenches postischemic leukosequestration and reduces stroke-induced neurological injury.


Subject(s)
Antigens, CD/biosynthesis , Antigens, CD/genetics , Apyrase/biosynthesis , Apyrase/genetics , Brain Ischemia/genetics , Brain Ischemia/metabolism , Cell Lineage/physiology , Transgenes/physiology , Animals , Brain Ischemia/prevention & control , Gene Expression , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myeloid Cells/physiology
2.
JCI Insight ; 2(1): e89504, 2017 01 12.
Article in English | MEDLINE | ID: mdl-28097233

ABSTRACT

Mechanical complications of myocardial infarction (MI) are often fatal. Little is known about endogenous factors that predispose to myocardial rupture after MI. Ectonucleoside triphosphate diphosphohydrolase (CD39) could be a critical mediator of propensity to myocardial rupture after MI due to its role in modulating inflammation and thrombosis. Using a model of permanent coronary artery ligation, rupture was virtually abrogated in cd39-/- mice versus cd39+/+ controls, with elevated fibrin and collagen deposition and marked neutrophil and macrophage influx. Macrophages were found to display increased surface expression of CD301 and CD206, marking a reparative phenotype, driven by increased extracellular ATP and IL-4 in the infarcted myocardium of cd39-/- mice. A myeloid-specific CD39-knockout mouse also demonstrated protection from rupture, with an attenuated rupture phenotype, suggesting that complete ablation of CD39 provides the greatest degree of protection in this model. Absence of CD39, either globally or in a myeloid lineage-restricted fashion, skews the phenotype toward alternatively activated (reparative) macrophage infiltration following MI. These studies reveal a previously unrecognized and unexpected role of endogenous CD39 to skew macrophage phenotype and promote a propensity to myocardial rupture after MI.


Subject(s)
Adenosine Triphosphatases/metabolism , Myocardial Infarction/metabolism , Myocardial Reperfusion Injury/metabolism , Myocardium/enzymology , Rupture/etiology , Animals , Antigens, CD/metabolism , Disease Models, Animal , Inflammation/metabolism , Macrophages/metabolism , Male , Mice , Mice, Knockout , Myocardial Infarction/complications , Myocardial Infarction/physiopathology , Myocardial Reperfusion Injury/physiopathology , Phenotype , Thrombosis/metabolism
3.
Circ Res ; 119(1): 142-58, 2016 06 24.
Article in English | MEDLINE | ID: mdl-27340273

ABSTRACT

Over the past several decades, there have been substantial advances in our knowledge of the pathophysiology of stroke. Understanding the benefits of timely reperfusion has led to the development of thrombolytic therapy as the cornerstone of current management of ischemic stroke, but there remains much to be learned about mechanisms of neuronal ischemic and reperfusion injury and associated inflammation. For ischemic stroke, novel therapeutic targets have continued to remain elusive. When considering modern molecular biological techniques, advanced translational stroke models, and clinical studies, a consistent pattern emerges, implicating perturbation of the immune equilibrium by stroke in both central nervous system injury and repair responses. Stroke triggers activation of the neuroimmune axis, comprised of multiple cellular constituents of the immune system resident within the parenchyma of the brain, leptomeninges, and vascular beds, as well as through secretion of biological response modifiers and recruitment of immune effector cells. This neuroimmune activation can directly impact the initiation, propagation, and resolution phases of ischemic brain injury. To leverage a potential opportunity to modulate local and systemic immune responses to favorably affect the stroke disease curve, it is necessary to expand our mechanistic understanding of the neuroimmune axis in ischemic stroke. This review explores the frontiers of current knowledge of innate and adaptive immune responses in the brain and how these responses together shape the course of ischemic stroke.


Subject(s)
Neuroimmunomodulation , Stroke/immunology , Adaptive Immunity , Animals , Blood-Brain Barrier/metabolism , Humans , Immunity, Innate , Stroke/metabolism
4.
Am J Physiol Heart Circ Physiol ; 311(1): H286-98, 2016 07 01.
Article in English | MEDLINE | ID: mdl-27208163

ABSTRACT

Despite the fact that nucleotides and adenosine help regulate vascular tone through purinergic signaling pathways, little is known regarding their contributions to the pathobiology of pulmonary arterial hypertension, a condition characterized by elevated pulmonary vascular resistance and remodeling. Even less is known about the potential role that alterations in CD39 (ENTPD1), the ectonucleotidase responsible for the conversion of the nucleotides ATP and ADP to AMP, may play in pulmonary arterial hypertension. In this study we identified decreased CD39 expression on the pulmonary endothelium of patients with idiopathic pulmonary arterial hypertension. We next determined the effects of CD39 gene deletion in mice exposed to normoxia or normobaric hypoxia (10% oxygen). Compared with controls, hypoxic CD39(-/-) mice were found to have a markedly elevated ATP-to-adenosine ratio, higher pulmonary arterial pressures, more right ventricular hypertrophy, more arterial medial hypertrophy, and a pro-thrombotic phenotype. In addition, hypoxic CD39(-/-) mice exhibited a marked increase in lung P2X1 receptors. Systemic reconstitution of ATPase and ADPase enzymatic activities through continuous administration of apyrase decreased pulmonary arterial pressures in hypoxic CD39(-/-) mice to levels found in hypoxic CD39(+/+) controls. Treatment with NF279, a potent and selective P2X1 receptor antagonist, lowered pulmonary arterial pressures even further. Our study is the first to implicate decreased CD39 and resultant alterations in circulating purinergic signaling ligands and cognate receptors in the pathobiology of pulmonary arterial hypertension. Reconstitution and receptor blocking experiments suggest that phosphohydrolysis of purinergic nucleotide tri- and diphosphates, or blocking of the P2X1 receptor could serve as treatment for pulmonary arterial hypertension.


Subject(s)
Antigens, CD/metabolism , Apyrase/metabolism , Hypertension, Pulmonary/metabolism , Lung/metabolism , Pulmonary Artery/metabolism , Receptors, Purinergic P2X1/metabolism , Adenosine/metabolism , Adenosine Triphosphate/metabolism , Animals , Antigens, CD/genetics , Antihypertensive Agents/pharmacology , Apyrase/deficiency , Apyrase/genetics , Apyrase/pharmacology , Arterial Pressure , Disease Models, Animal , Genetic Predisposition to Disease , Humans , Hydrolysis , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/genetics , Hypertension, Pulmonary/physiopathology , Hypertrophy, Right Ventricular/genetics , Hypertrophy, Right Ventricular/metabolism , Hypertrophy, Right Ventricular/physiopathology , Hypoxia/complications , Lung/drug effects , Mice, Inbred C57BL , Mice, Knockout , Phenotype , Pulmonary Artery/drug effects , Pulmonary Artery/physiopathology , Purinergic P2X Receptor Antagonists/pharmacology , Receptors, Purinergic P2X1/drug effects , Severity of Illness Index , Signal Transduction , Suramin/analogs & derivatives , Suramin/pharmacology , Vascular Remodeling , Ventricular Remodeling
5.
Cardiovasc Res ; 98(1): 116-24, 2013 Apr 01.
Article in English | MEDLINE | ID: mdl-23334216

ABSTRACT

AIMS: Electrophilic fatty acid nitroalkene derivatives, products of unsaturated fatty acid nitration, exert long-term cardiovascular protection in experimental models of metabolic and cardiovascular diseases. The goal of this study is to examine the effects of nitro-fatty acids in the regulation of upstream signalling events in nuclear factor-κB (NF-κB) activation and determine whether low-dose acute administration of nitro-fatty acids reduces vascular inflammation in vivo. METHODS AND RESULTS: Using NF-κB-luciferase transgenic mice, it was determined that pre-emptive treatment with nitro-oleic acid (OA-NO2), but not oleic acid (OA) inhibits lipopolysaccharide (LPS)-induced NF-κB activation both in vivo and in isolated macrophages. Acute intravenous administration of OA-NO2 was equally effective to inhibit leukocyte recruitment to the vascular endothelium assessed by intravital microscopy and significantly reduces aortic expression of adhesion molecules. An acute treatment with OA-NO2 in vivo yielding nanomolar concentrations in plasma, is sufficient to inhibit LPS-induced Toll-like receptor 4 (TLR4)-induced cell surface expression in leukocytes and NF-κB activation. In vitro experiments reveal that OA-NO2 suppresses LPS-induced TLR4 signalling, inhibitor of κB (IκBα) phosphorylation and ubiquitination, phosphorylation of the IκB kinase (IKK), impairing the recruitment of the TLR4 and TNF receptor associated factor 6 (TRAF6) to the lipid rafts compartments. CONCLUSION: These studies demonstrate that acute administration of nitro-fatty acids is effective to reduce vascular inflammation in vivo. These findings reveal a direct role of nitro-fatty acids in the disruption of the TLR4 signalling complex in lipid rafts, upstream events of the NF-κB pathway, leading to resolution of pro-inflammatory activation of NF-κB in the vasculature.


Subject(s)
Lipopolysaccharides/pharmacology , Membrane Microdomains/metabolism , Nitric Oxide/pharmacology , Oleic Acids/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology , Toll-Like Receptor 4/physiology , Vasculitis/prevention & control , Animals , Cell Adhesion/drug effects , Cells, Cultured , Humans , Mice , Mice, Inbred C57BL , NF-kappa B/metabolism , Phosphorylation , Toll-Like Receptor 4/analysis
6.
J Immunol ; 188(5): 2387-98, 2012 Mar 01.
Article in English | MEDLINE | ID: mdl-22291183

ABSTRACT

Ectoenzymes expressed on the surface of vascular cells and leukocytes modulate the ambient nucleotide milieu. CD73 is an ecto-5' nucleotidase that catalyzes the terminal phosphohydrolysis of AMP and resides in the brain on glial cells, cells of the choroid plexus, and leukocytes. Though CD73 tightens epithelial barriers, its role in the ischemic brain remains undefined. When subjected to photothrombotic arterial occlusion, CD73(-/-) mice exhibited significantly larger (49%) cerebral infarct volumes than wild-type mice, with concordant increases in local accumulation of leukocyte subsets (neutrophils, T lymphocytes, macrophages, and microglia). CD73(-/-) mice were rescued from ischemic neurologic injury by soluble 5'-nucleotidase. In situ, CD73(-/-) macrophages upregulated expression of costimulatory molecules far more than wild-type macrophages, with a sharp increase of the CD80/CD86 ratio. To define the CD73-bearing cells responsible for ischemic cerebroprotection, mice were subjected to irradiative myeloablation, marrow reconstitution, and then stroke following engraftment. Chimeric mice lacking CD73 in tissue had larger cerebral infarct volumes and more tissue leukosequestration than did mice lacking CD73 on circulating cells. These data show a cardinal role for CD73 in suppressing ischemic tissue leukosequestration. This underscores a critical role for CD73 as a modulator of brain inflammation and immune function.


Subject(s)
5'-Nucleotidase/physiology , Brain Ischemia/immunology , Brain Ischemia/pathology , Cell Movement/genetics , Cell Movement/immunology , Leukocytes/immunology , Leukocytes/pathology , 5'-Nucleotidase/deficiency , 5'-Nucleotidase/genetics , Adenosine/biosynthesis , Adenosine/physiology , Animals , Bone Marrow Transplantation/immunology , Bone Marrow Transplantation/pathology , Brain Edema/enzymology , Brain Edema/immunology , Brain Edema/pathology , Brain Ischemia/enzymology , Extracellular Fluid/enzymology , Extracellular Fluid/immunology , Infarction, Middle Cerebral Artery/enzymology , Infarction, Middle Cerebral Artery/immunology , Infarction, Middle Cerebral Artery/pathology , Inflammation/enzymology , Inflammation/immunology , Inflammation/prevention & control , Leukocytes/enzymology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Signal Transduction/genetics , Signal Transduction/immunology , Tissue Distribution/genetics , Tissue Distribution/immunology
7.
Neurol Res ; 33(7): 717-25, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21756551

ABSTRACT

OBJECTIVES: Early growth response gene-1 (Egr-1) coordinates the rapid upregulation of diverse inflammatory and coagulation-related genes following ischemia/reperfusion. Genetic deletion of Egr-1 results in attenuated post-ischemic injury in diverse tissue systems. In the present study, we utilized a murine model of transient middle cerebral artery occlusion to probe the functional effects of Egr-1 deletion following cerebral ischemia/reperfusion. METHODS: The time course of Egr-1 expression was established by Northern/Western blot analysis, and immunocytochemistry localized Egr-1 to specific cell populations. Flow cytometry was then employed to characterize the ischemic cellular infiltrate of both wild-type (+/+) and Egr-1-null (-/-) mice. Next, the functional effect of Egr-1 deletion was investigated in Egr-1-deficient mice and their wild-type littermates subjected to middle cerebral artery occlusion. Infarct volumes, neurological scores, and reperfusion cerebral blood flow were compared between cohorts. RESULTS: Rapid upregulation of Egr-1 was observed in the ischemic hemisphere, and localized primarily to neurons and mononuclear cells. Egr-1 deletion led to a suppression of infiltrating neutrophils and activated microglia/macrophages (P<0.001). Additionally, although Egr-1 deletion enhanced post-ischemic cerebral blood flow, Egr-1-deficient mice suffered larger infarcts (P=0.01) and demonstrated a trend towards worse neurological scores (P=0.06) than wild-type controls. DISCUSSION: Despite a reduction in the proportion of infiltrating inflammatory cells/activated microglia and improvement in post-ischemic reperfusion, Egr-1-deficient animals suffer larger infarcts in our model. Therefore, cerebral Egr-1 expression may function to protect neurons despite its adverse modulatory consequences for inflammation and thrombosis.


Subject(s)
Cerebrovascular Circulation/physiology , Early Growth Response Protein 1/biosynthesis , Early Growth Response Protein 1/genetics , Infarction, Middle Cerebral Artery/physiopathology , Neurons/pathology , Reperfusion Injury/immunology , Reperfusion Injury/physiopathology , Animals , Cerebral Cortex/blood supply , Cerebral Cortex/immunology , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cerebrovascular Circulation/genetics , Disease Models, Animal , Infarction, Middle Cerebral Artery/genetics , Ischemic Attack, Transient/genetics , Ischemic Attack, Transient/physiopathology , Macrophage Activation/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Monocytes/metabolism , Neurons/metabolism , Neutrophils/physiology , Reperfusion Injury/metabolism , Up-Regulation
8.
Am J Physiol Renal Physiol ; 301(3): F660-71, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21632959

ABSTRACT

The state-of-the-art cultured podocyte is conditionally immortalized by expression of a temperature-sensitive mutant of the SV40 large-T antigen. These cultures proliferate at 33°C and differentiate at 37°C into arborized cells that more closely resemble in vivo podocytes. However, the degree of resemblance remains controversial. In this study, several parameters were measured in podocyte cell lines derived from mouse (JR, KE), human (MS), and rat (HK). In all lines, the quantities of NEPH1 and podocin proteins and NEPH1 and SYNPO mRNAs were comparable to glomeruli, while synaptopodin and nephrin proteins and NPHS1 and NPHS2 mRNAs were <5% of glomerular levels. Expression of Wilms' tumor-1 (WT1) mRNA in mouse lines was comparable to glomeruli, but rat and human lines expressed little WT1. Undifferentiated human and mouse lines had similar proliferation rates that decreased after differentiation, while the rate in rat cells remained constant. The motility of different lines varied as measured by both general motility and wound-healing assays. The toxicity of puromycin aminonucleoside was MS ∼ JR >> KE, and of doxorubicin was JR ∼ KE > MS, while HK cells were almost unaffected. Process formation was largely a result of contractile action after formation of lamellipodia. These findings demonstrate dramatic differences in marker expression, response to toxins, and motility between lines of podocytes from different species and even between similarly-derived mouse lines.


Subject(s)
Cell Differentiation/physiology , Cell Proliferation , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/metabolism , Microfilament Proteins/metabolism , Podocytes/cytology , Podocytes/metabolism , Animals , Biomarkers/metabolism , Cell Death/drug effects , Cell Line , Cell Movement/physiology , Cells, Cultured , Doxorubicin/pharmacology , Humans , Male , Mice , Models, Animal , Podocytes/drug effects , Puromycin Aminonucleoside/pharmacology , Rats , Rats, Sprague-Dawley , Species Specificity , WT1 Proteins/metabolism
9.
J Clin Invest ; 119(5): 1136-49, 2009 May.
Article in English | MEDLINE | ID: mdl-19381014

ABSTRACT

Leukocyte and platelet accumulation at sites of cerebral ischemia exacerbate cerebral damage. The ectoenzyme CD39 on the plasmalemma of endothelial cells metabolizes ADP to suppress platelet accumulation in the ischemic brain. However, the role of leukocyte surface CD39 in regulating monocyte and neutrophil trafficking in this setting is not known. Here we have demonstrated in mice what we believe to be a novel mechanism by which CD39 on monocytes and neutrophils regulates their own sequestration into ischemic cerebral tissue, by catabolizing nucleotides released by injured cells, thereby inhibiting their chemotaxis, adhesion, and transmigration. Bone marrow reconstitution and provision of an apyrase, an enzyme that hydrolyzes nucleoside tri- and diphosphates, each normalized ischemic leukosequestration and cerebral infarction in CD39-deficient mice. Leukocytes purified from Cd39-/- mice had a markedly diminished capacity to phosphohydrolyze adenine nucleotides and regulate platelet reactivity, suggesting that leukocyte ectoapyrases modulate the ambient vascular nucleotide milieu. Dissipation of ATP by CD39 reduced P2X7 receptor stimulation and thereby suppressed baseline leukocyte alphaMbeta2-integrin expression. As alphaMbeta2-integrin blockade reversed the postischemic, inflammatory phenotype of Cd39-/- mice, these data suggest that phosphohydrolytic activity on the leukocyte surface suppresses cell-cell interactions that would otherwise promote thrombosis or inflammation. These studies indicate that CD39 on both endothelial cells and leukocytes reduces inflammatory cell trafficking and platelet reactivity, with a consequent reduction in tissue injury following cerebral ischemic challenge.


Subject(s)
Antigens, CD/physiology , Apyrase/physiology , Cell Movement/physiology , Leukocytes/cytology , 5'-Nucleotidase/antagonists & inhibitors , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Apyrase/pharmacology , Bone Marrow Transplantation , Brain Ischemia/genetics , Brain Ischemia/pathology , Cell Line, Tumor , Cell Movement/drug effects , Endothelial Cells/metabolism , Enzyme Inhibitors/pharmacology , Leukocytes/drug effects , Leukocytes/metabolism , Macrophage-1 Antigen/immunology , Macrophage-1 Antigen/metabolism , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mice , Mice, Inbred Strains , Mice, Knockout , Monocytes/cytology , Monocytes/drug effects , Monocytes/metabolism , Neutrophils/cytology , Neutrophils/metabolism , Platelet Activation/physiology , Purinergic P2 Receptor Antagonists , RNA Interference , Receptors, Purinergic P2/genetics , Transplantation Chimera/physiology
10.
Regul Pept ; 142(3): 101-10, 2007 Aug 16.
Article in English | MEDLINE | ID: mdl-17391781

ABSTRACT

It is well known that somatostatin modulates thymic functions, such as binding to receptors. In order to elucidate the influence of somatostatin on the thymus architecture and the T cells maturation, young adult male rats were treated with somatostatin-28. The results showed that somatostatin-28 decreased thymus weight and cellularity, probably due to alterations in the thymic morphometric parameters. Our results also demonstrated that SRIH treatment reduces number of cells with undetectable alphabetaTCR and cells with low expression of alphabetaTCR, while the number of TCRalphabeta(hi) cells remains approximately the same as the values obtained from the control rats. Besides, in the least mature thymocytes (DNTCR TCRalphabeta(-)) and among the most mature the SPCD4 TCRalphabeta(hi) subset remained unaltered, while SPCD8 TCRalphabeta(hi) decreased. At last, it should be noted that SRIH treatment increases DN thymocytes subsets expressing TCRalphabeta(low/hi) (TCRalphabeta(+)). These results suggest that somatostatin-28 induces reshaping of T cells maturation and, at least partly, contributes to thymic weight loss, through the modulation of the complex neuroendocrine-immune network.


Subject(s)
Somatostatin-28/pharmacology , T-Lymphocyte Subsets/drug effects , Thymus Gland/drug effects , Animals , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Cell Count , Cell Cycle/drug effects , Cell Differentiation/drug effects , Male , Neuroimmunomodulation/drug effects , Neurosecretory Systems/drug effects , Organ Size/drug effects , Rats , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Receptors, Somatostatin/metabolism , Recombinant Proteins/pharmacology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , Thymus Gland/cytology , Thymus Gland/immunology
11.
Am J Physiol Lung Cell Mol Physiol ; 293(1): L124-30, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17384085

ABSTRACT

Chronic airway rejection, characterized by lymphocytic bronchitis, epithelial cell damage, and obliterative bronchiolitis (OB), limits long-term survival after lung transplantation. The transcription factor early growth response gene-1 (Egr-1) induces diverse inflammatory mediators, some involved in OB pathogenesis. An orthotopic mouse tracheal transplant model was used to determine whether Egr-1 promotes development of airway allograft rejection. Significantly higher Egr-1 mRNA levels were seen in allografts (3.2-fold increase vs. isografts, P = 0.012). Allografts revealed thickening of epithelial and subepithelial airway layers (51 +/- 4% luminal encroachment for allografts vs. 20 +/- 3% for isografts, P < 0.0001) marked by significant lymphocytic infiltration. Absence of the Egr-1 gene in donor (but not recipient) tissue resulted in significant reduction in luminal narrowing (34 +/- 4%, P = 0.0001) with corresponding diminution of T cell infiltration. Egr-1 null allografts exhibited a striking reduction in inducible nitric oxide synthase (iNOS) expression. Effector cytokines previously implicated in OB pathogenesis with known Egr-1 promoter motifs (IL-1beta and JE/monocyte chemoattractant protein-1) were reduced in Egr-1 null allografts. These data suggest a paradigm wherein local induction of Egr-1 in tracheal allografts drives expression of inflammatory mediators responsible for lymphocyte recruitment and tissue destruction characteristic of airway rejection.


Subject(s)
Early Growth Response Protein 1/genetics , Graft Rejection/metabolism , Lung Transplantation , Animals , CD3 Complex/metabolism , Cytokines/blood , Early Growth Response Protein 1/metabolism , Gene Expression Regulation , Leukocytes, Mononuclear/cytology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Nitric Oxide Synthase Type II/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Time Factors , Transplantation, Homologous
12.
Acta Histochem ; 106(6): 449-58, 2005.
Article in English | MEDLINE | ID: mdl-15707654

ABSTRACT

Various stressors induce changes in the immune system. However, it has not yet been analyzed how stressors affect thymus innervation. To examine whether chronic stress alters the morphology of the thymus by changing the nerve components of the thymus, adult male rats, 9-weeks old, were exposed to forced swimming during 21 successive days. The animals were sacrificed by decapitation after the last session and their thymuses were used for analysis of (i) the thymus compartments, (ii) distribution patterns of monoamine-containing nerve profiles and (iii) distribution patterns of acetylcholinesterase (AChE)-containing nerve profiles. Our results show that chronic stress in rats reduces the volume of both thymus cortex and medulla, numbers of thymocytes in the deep cortex and medulla and the density of fluorescent nerve profiles, whereas it increases density of fluorescent cells. The distribution patterns of nerve profiles containing monoamine and AChE were not affected. These changes indicate that chronic stress affects thymus development and T cell maturation by altering the sympathetic nerve component.


Subject(s)
Aging/physiology , Stress, Physiological/physiopathology , Thymus Gland/innervation , Acetylcholinesterase/metabolism , Amines/metabolism , Animals , Chronic Disease , Male , Nerve Fibers/enzymology , Nerve Fibers/metabolism , Organ Size , Rats , Swimming/physiology , Thymus Gland/anatomy & histology , Thymus Gland/metabolism
13.
J Neuroimmunol ; 160(1-2): 77-86, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15710460

ABSTRACT

The aim of this study was to investigate whether chronic stress, induced by repeated daily swimming during 21 days, alters the morphofunctional parameters in the thymus of adult rats. Our results showed that chronic stress reduced thymus mass, total number of thymocytes, volume of the thymus compartments and numerical density of thymocytes within thymus inner cortex and medulla. However, the percentage of apoptotic cells and the level of corticosterone were significantly increased. The percentages of CD4-CD8-TCRalphabeta(low/high) and CD4-CD8+TCRalphabeta(-)thymocytes were significantly increased, while the percentage of the least mature CD4+CD8-SP TCRalphabeta(-) thymocytes was significantly decreased. These results show that recurred swimming procedure induces thymus hypotrophy and elevated percentage of DN TCRalphabeta(+) cells.


Subject(s)
Stress, Physiological/immunology , Stress, Physiological/physiopathology , Swimming/physiology , Thymus Gland/physiopathology , Animals , Apoptosis/immunology , CD4-CD8 Ratio , Corticosterone/blood , Flow Cytometry , Lymphopenia/immunology , Lymphopenia/pathology , Lymphopenia/physiopathology , Male , Organ Size/immunology , Rats , Rats, Inbred Strains , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Stress, Physiological/pathology , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Thymus Gland/metabolism , Thymus Gland/pathology
14.
Histochem J ; 34(11-12): 573-82, 2002.
Article in English | MEDLINE | ID: mdl-14626348

ABSTRACT

The aim of this study was to investigate the effects of centrally applied somatostatin-28 on morphometric characteristics of the thymus, the thymocyte subpopulations, as well as, on apoptosis and phases of cell cycle in thymocytes. For this purpose, peripubertal male rats were cannulated intracerebroventriculary and treated with repeated, nanomolar concentrations of somatostatin-28 (experimental group) or saline (control group). Animals were sacrificed and their thymuses were used for the analysis of thymocyte subpopulations, cell cycle and apoptosis by flow cytometry and for the evaluation of morphometric parameters by stereological analysis. Our results showed that somatostatin-28 caused decrease of the thymic mass and volume, as well as total thymocytes number. Stereological analysis revealed volume decrease of thymic cortex and medulla accompanied with cellularity decrease. Somatostatin in the deeper cortex decreased the number of thymocytes, per volume unit, while in outer cortex raised their number. A significant increase in the percentage of double-negative and both single-positive thymocyte subpopulations, in parallel with a diminished percentage of double-positive cells was found. The cellularity of double-positive and single-positive thymocyte subpopulations was decreased. Somatostatin-28 treatment augmented the percentage of apoptotic cells, while the percentage of the cells represented in phases of cell cycle was reduced. These results suggest that somatostatin-28 induce thymus hypotrophy as result of decreasing cortex and medulla volume and cellularity. Changes in the percentage and cellularity of thymocyte subpopulations and numerical density of thymocytes in outer and deeper cortex, indicate that somatostatin-28 evoked disturbance in transition of double-negative to double-positive thymocytes.


Subject(s)
Protein Precursors/pharmacology , Somatostatin/pharmacology , Thymus Gland/drug effects , Animals , Apoptosis/drug effects , Body Weight/drug effects , Cell Count , Cell Cycle , DNA/analysis , Flow Cytometry , Injections, Intraventricular , Male , Organ Size/drug effects , Protein Precursors/administration & dosage , Rats , Rats, Inbred Strains , Sexual Maturation/physiology , Somatostatin/administration & dosage , Somatostatin-28 , Thymus Gland/growth & development , Thymus Gland/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...